World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
46033
World Ranking
6984
National Ranking
264

Flora E. van Leeuwen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Flora E. van Leeuwen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 437 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Flora E. van Leeuwen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Flora E. van Leeuwen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Flora E. van Leeuwen is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their work primarily focuses on the field of medicine with a strong emphasis on oncology and related subfields.

The scientist's research spans 292 publications in medicine, including significant contributions in the following subfields:

  • Oncology
  • Pediatrics, Perinatology and Child Health
  • Pathology and Forensic Medicine
  • Genetics
  • Surgery

Key topics addressed in van Leeuwen's work include:

  • Childhood Cancer Survivors' Quality of Life
  • Cancer Risks and Factors
  • BRCA gene mutations in cancer
  • Lymphoma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Genetic factors in colorectal cancer
  • Chemotherapy-induced cardiotoxicity and mitigation

Their recent papers cover various aspects of cancer surveillance, risk assessment, and treatment, notably:

  • Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer (2020), published in Journal of Clinical Oncology
  • Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients (2020), published in JNCI Journal of the National Cancer Institute
  • Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study (2021), published in JNCI Journal of the National Cancer Institute
  • Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020), published in Breast Cancer Research
  • Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma (2020), published in Blood

Van Leeuwen frequently publishes in several prominent journals, with the highest number of contributions in:

  • Journal of Clinical Oncology
  • JNCI Journal of the National Cancer Institute
  • Human Reproduction
  • HemaSphere
  • Cancer

Their collaborative work includes partnerships with several frequent co-authors, notably:

  • Michael Schaapveld
  • Berthe M.P. Aleman
  • Leontien C.M. Kremer
  • Cécile P.M. Janus
  • Cécile M. Ronckers

Best Publications

  • Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    Karoline B. Kuchenbaecker;Karoline B. Kuchenbaecker;John L. Hopper;Daniel R. Barnes;Kelly-Anne Phillips

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Medical assessment of adverse health outcomes in long-term survivors of childhood cancer

    Maud M. Geenen;Mathilde C. Cardous-Ubbink;Leontien C. M. Kremer;Cor van den Bos

  • Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.

    Maartje J. Hooning;Akke Botma;Berthe M. P. Aleman;Margreet H. A. Baaijens

  • Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

    Berthe M.P. Aleman;Alexandra W. van den Belt-Dusebout;Willem J. Klokman;Mars B. van’t Veer

  • Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

    Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch

  • Late cardiotoxicity after treatment for Hodgkin lymphoma

    Berthe M. P. Aleman;Alexandra W. van den Belt-Dusebout;Marie L. De Bruin;Mars B. van 't Veer

  • Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

    Lois B. Travis;Deirdre A. Hill;Graça M. Dores;Mary Gospodarowicz

  • Risk of endometrial cancer after tamoxifen treatment of breast cancer

    F.E. van Leeuwen;A.W. van den Belt-Dusebout;J. Benraadt;F.W. Diepenhorst

  • Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

    Graça M. Dores;Catherine Metayer;Rochelle E. Curtis;Charles F. Lynch

  • Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease

    Lois B. Travis;Mary Gospodarowicz;Rochelle E. Curtis;E. Aileen Clarke

  • Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits

    G.C. van Rhoon;A. Aleman;G. Kelfkens;H. Kromhout

  • Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

    Lois B. Travis;Rochelle E. Curtis;Joseph F. Fraumeni;John D. Boice

  • Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

    Liesbeth Bergman;Maureen L R Beelen;Maarten P W Gallee;Harry Hollema

  • Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

    Michael Schaapveld;Berthe M.P. Aleman;Anna M. van Eggermond;Cécile P.M. Janus

  • Leukemia following Hodgkin's disease.

    Kaldor Jm;Day Ne;Clarke Ea;Van Leeuwen Fe

  • Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.

    Flora E. van Leeuwen;Willem J. Klokman;Mars B. van t Veer;Anton Hagenbeek

  • Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

    Alexandra W. van den Belt-Dusebout;Ronald de Wit;Jourik A. Gietema;Simon Horenblas

  • Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

    Lois B. Travis;Deirdre Hill;Graça M. Dores;Mary Gospodarowicz

  • Risk and Prognosis of Endometrial Cancer After Tamoxifen for Breast Cancer

    L. R. Beelen;Maarten P. W. Gallee;Harry Hollema;Jantien Benraadt

Frequent Co-Authors

Marjanka K. Schmidt
Marjanka K. Schmidt Antoni van Leeuwenhoek Hospital
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Douglas F. Easton
Douglas F. Easton University of Cambridge
Annegien Broeks
Annegien Broeks Antoni van Leeuwenhoek Hospital
Antonis C. Antoniou
Antonis C. Antoniou University of Cambridge
Otto Visser
Otto Visser VU University Medical Center
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Marilyn Stovall
Marilyn Stovall The University of Texas MD Anderson Cancer Center
David E. Goldgar
David E. Goldgar University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a range of flexible, accelerated online nursing and healthcare degrees. For those seeking advanced roles, accelerated msn to dnp programs offer a fast-tracked path from a Master of Science in Nursing (MSN) to the highest clinical nursing degree (DNP), often designed for working professionals who want career advancement.

Budget-conscious students may benefit from exploring the cheapest dnp program options online. These programs make it easier for students to acquire a high-demand credential without overwhelming student debt, broadening access to advanced practice positions.

If you are starting your nursing journey, a lpn accelerated program provides an efficient entry point to the healthcare workforce in months rather than years. For those interested in mental health, the fastest psych np program offers direct advancement to becoming a Psychiatric-Mental Health Nurse Practitioner—meeting a growing area of demand.

These online degree options support diverse career ambitions, allowing future healthcare leaders to tailor their education and fast-track their professional growth.

Best Scientists Citing Flora E. van Leeuwen

Trending Scientists

Recently Published Articles